Colon Cancer Market Size, Share, Analysis, Forecast, Industry Strategy, Opportunity, Trends, Insights, Growth, Price, Research Survey, Segment, Outlook and Challenges Report To 2016
Colon Cancer Market Size, Share, Analysis, Forecast, Industry Strategy, Opportunity, Trends, Insights, Growth, Price, Research Survey, Segment, Outlook and Challenges Report To 2016
Market Reports Center latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer Pipeline Review, H2 2016, provides an overview of the Colon Cancer( Oncology) pipeline landscape.
Colon cancer is cancer that starts in the large intestine( colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous( benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools and weight loss with no known reason. Treatment includes surgery, radiation therapy and chemotherapy.
Report Highlights
Market Reports Center Pharmaceutical and Healthcare latest pipeline guide Colon Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Colon Cancer( Oncology), complete with analysis by stage of development, drug target, mechanism of action( MoA), route of administration( RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
To know more about this report, Click here: https:// marketreportscenter. com / reports / 490762 / colon-cancer-pipeline-review-h2-2016
The Colon Cancer( Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colon Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies / Universities / Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND / CTA Filed, Preclinical and Discovery stages are 1, 6, 35, 3, 155 and 14 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 2, 2, 46 and 16 molecules, respectively.
Colon Cancer( Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create